journal article·2023-02

Chiral‐Selective Antigen‐Presentation by Supramolecular Chiral Polymer Micelles

Hejin Jiang, Rui Liu, Lu Wang, Xinyue Wang, Mengmeng Zhang, Sisi Lin, Zhenping Cao, Feng Wu, Yingbin Liu, Jinyao Liu

Advanced Materials· Volume 35· Issue 5
Publisher page

Abstract

Abstract Chirality is ubiquitous in biological systems, which is closely related to biological functions, life processes, and even the pathogenesis of diseases. However, the interface between the chirality of synthetic materials and organisms, particularly the immune system, remains poorly understood. Here, supramolecular chiral polymer micelles (SCPMs) are prepared by complexing antigenic proteins with chiral amino acid‐modified polyethyleneimine. The introduction of chirality not only reduces the toxicity of cationic polymer, but also benefits cell uptake and antigen presentation. Especially, D‐chirality presents the lowest cytotoxicity, while promoting the highest expression level of costimulatory molecules on dendritic cells compared to L‐chirality and achirality. The superiority of D‐chirality to stimulate dendritic cell maturation is supported by immunization with D‐SCPMs, which achieves significant antigen‐specific proliferation of T cells in the spleen, lymph nodes, and tumor of mice. Chirality‐mediated antigen processing and presentation are demonstrated by D‐SCPMs self‐assembled from chiral alkaline histidine or neutral phenylalanine modified polyethyleneimine and tumor associated ovalbumin or severe acute respiratory syndrome coronavirus 2 spike 1 antigenic protein. Immunoactivation enabled by D‐chirality opens a window to prepare potent nanotherapeutics for disease prevention and treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Supramolecular Self-Assembly in Materials · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oncogenes and Related Genes Shanghai Cancer Institute Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine Institute of Molecular Medicine Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

Department of Biliary‐Pancreatic Surgery Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (65)

Show source-provided references
1. 10.1021/cr500671p10.1021/cr500671p ↗
2. 10.1021/acs.accounts.8b0031210.1021/acs.accounts.8b00312 ↗
3. 10.1021/acs.accounts.0c0001210.1021/acs.accounts.0c00012 ↗
4. 10.1007/BF0158158110.1007/BF01581581 ↗
5. 10.1002/(SICI)1521-3773(19991203)38:23<3418::AID-ANIE3418>3.0.CO;2-V10.1002/(SICI)1521-3773(19991203)38:23<3418::AID-ANIE3418>3.0.CO;2-V ↗
6. 10.1126/science.abb182210.1126/science.abb1822 ↗
7. 10.1021/acs.jpclett.0c0214410.1021/acs.jpclett.0c02144 ↗
8. 10.1038/nrd91510.1038/nrd915 ↗
9. 10.1038/nature0199010.1038/nature01990 ↗
10. 10.1007/s00431005079310.1007/s004310050793 ↗
11. 10.1002/adma.20210513610.1002/adma.202105136 ↗
12. 10.1038/nature1076910.1038/nature10769 ↗
13. 10.1038/nnano.2017.4210.1038/nnano.2017.42 ↗
14. 10.1038/s41467-021-27708-410.1038/s41467-021-27708-4 ↗
15. 10.1158/0008-5472.CAN-10-389410.1158/0008-5472.CAN-10-3894 ↗
16. 10.1038/s41467-020-18525-210.1038/s41467-020-18525-2 ↗
17. 10.1021/acs.chemrev.6b0035410.1021/acs.chemrev.6b00354 ↗
18. 10.1016/j.chempr.2018.12.00610.1016/j.chempr.2018.12.006 ↗
19. 10.1039/C1CS15209B10.1039/C1CS15209B ↗
20. 10.1021/ja504962610.1021/ja5049626 ↗
21. 10.1021/am504702p10.1021/am504702p ↗
22. 10.1002/anie.20140324910.1002/anie.201403249 ↗
23. 10.1126/science.812822110.1126/science.8128221 ↗
24. 10.1038/s41467-017-02268-810.1038/s41467-017-02268-8 ↗
25. 10.1002/adma.20190058210.1002/adma.201900582 ↗
26. 10.1002/anie.20210160910.1002/anie.202101609 ↗
27. 10.1021/jacs.6b0978310.1021/jacs.6b09783 ↗
28. 10.1021/ja310019x10.1021/ja310019x ↗
29. 10.1002/anie.20181428210.1002/anie.201814282 ↗
30. 10.1002/adma.20190387810.1002/adma.201903878 ↗
31. 10.1038/s41586-021-04243-210.1038/s41586-021-04243-2 ↗
32. 10.1038/nnano.2013.23410.1038/nnano.2013.234 ↗
33. 10.2174/138161282166615102715290710.2174/1381612821666151027152907 ↗
34. 10.1016/j.ymthe.2005.02.01010.1016/j.ymthe.2005.02.010 ↗
35. 10.1021/bm400462810.1021/bm4004628 ↗
36. 10.1038/s41563-018-0028-210.1038/s41563-018-0028-2 ↗
37. 10.1002/advs.20200257710.1002/advs.202002577 ↗
38. 10.1007/s12274-021-3622-610.1007/s12274-021-3622-6 ↗
39. 10.1038/s41565-020-00781-410.1038/s41565-020-00781-4 ↗
40. 10.1016/j.chempr.2018.05.01610.1016/j.chempr.2018.05.016 ↗
41. 10.1002/bies.20220000210.1002/bies.202200002 ↗
42. 10.1038/s41563-020-00844-w10.1038/s41563-020-00844-w ↗
43. 10.1038/s41586-018-0705-y10.1038/s41586-018-0705-y ↗
44. 10.1007/s10904-014-0067-310.1007/s10904-014-0067-3 ↗
45. 10.1038/s41467-020-18570-x10.1038/s41467-020-18570-x ↗
46. 10.1021/acs.molpharmaceut.7b0001510.1021/acs.molpharmaceut.7b00015 ↗
47. 10.1038/377071a010.1038/377071a0 ↗
48. 10.1038/nature2134910.1038/nature21349 ↗
49. 10.1038/s41467-017-01651-910.1038/s41467-017-01651-9 ↗
50. 10.1038/s41551-018-0262-610.1038/s41551-018-0262-6 ↗
51. 10.1021/acsnano.8b0595010.1021/acsnano.8b05950 ↗
52. 10.1038/s41586-021-03365-x10.1038/s41586-021-03365-x ↗
53. 10.1002/adbi.20180021910.1002/adbi.201800219 ↗
54. 10.1038/s41467-018-03915-410.1038/s41467-018-03915-4 ↗
55. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
56. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
57. 10.1002/adma.20190125510.1002/adma.201901255 ↗
58. 10.1038/s41563-020-0793-610.1038/s41563-020-0793-6 ↗
59. 10.1038/nri77810.1038/nri778 ↗
60. 10.1038/ni.270310.1038/ni.2703 ↗
61. 10.1038/s41423-020-00530-610.1038/s41423-020-00530-6 ↗
62. 10.1038/nnano.2013.25410.1038/nnano.2013.254 ↗
63. 10.1126/science.abc626110.1126/science.abc6261 ↗
64. 10.1126/science.abd307210.1126/science.abd3072 ↗
65. 10.1126/science.abl946310.1126/science.abl9463 ↗